ConductScience.org, home

Paper37446271

Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.

Puzderova B and 7 others. Int J Mol Sci, 2023. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX. Papers, record 37446271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37446271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
2.2
iCite
Revised in PubMed
2023-07-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Puzderova BBarbora
2Belvoncikova PPetra
3Grossmannova KKatarina
4Csaderova LLucia
5Labudova MMartinahttps://orcid.org/0000-0002-3197-9763
6Fecikova SSilvia
7Pastorek JJaromir
8Barathova MMonika

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PropranololMajor topic
NeoplasmsMajor topic
Humans
Animals
Mice
Carbonic Anhydrase IX
Tumor Microenvironment
Antigens, Neoplasm
Fluorouracil
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
APVV-20-0485Research & Developmental Support AgencyPubMed
VEGA 2/090/20Slovak Scientific Grant AgencyPubMed
IMTS: 313011V446Operational Programme Integrated Infrastructure for the project: Integrative strategy in devel-opment of personalized medicine of selected malignant tumors and its impact on quality of lifePubMed

Source PubMed

Download CSV of grants

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110631692The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.Oncologist1999https://conductscience.org/library/papers/10631692PubMed
231540045Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges.Cells2019https://conductscience.org/library/papers/31540045PubMed
315556624Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.FEBS Lett2004https://conductscience.org/library/papers/15556624PubMed
422807646Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint.Clin Epidemiol2012https://conductscience.org/library/papers/22807646PubMed
521094927Biobehavioral influences on cancer progression.Immunol Allergy Clin North Am2011https://conductscience.org/library/papers/21094927PubMed
625098269FAK in cancer: mechanistic findings and clinical applications.Nat Rev Cancer2014https://conductscience.org/library/papers/25098269PubMed
716508637
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
Br J Cancer2006https://conductscience.org/library/papers/16508637PubMed
827308436Role of the autonomic nervous system in tumorigenesis and metastasis.Mol Cell Oncol2015https://conductscience.org/library/papers/27308436PubMed
98178713Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.Adv Exp Med Biol1993https://conductscience.org/library/papers/8178713PubMed
1011156414Hypoxia-inducible expression of tumor-associated carbonic anhydrases.Cancer Res2000https://conductscience.org/library/papers/11156414PubMed
1135956154Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.J Clin Med2022https://conductscience.org/library/papers/35956154PubMed
1236067803Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells.Eur J Pharmacol2022https://conductscience.org/library/papers/36067803PubMed
1321833026Dysregulated pH: a perfect storm for cancer progression.Nat Rev Cancer2011https://conductscience.org/library/papers/21833026PubMed
1436604116Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.Gut2023https://conductscience.org/library/papers/36604116PubMed
159748116The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.Clin Cancer Res1998https://conductscience.org/library/papers/9748116PubMed
1611705873Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.Clin Cancer Res2001https://conductscience.org/library/papers/11705873PubMed
1726772662Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis.Pediatrics2016https://conductscience.org/library/papers/26772662PubMed
18325360125-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes.Cancer Sci2020https://conductscience.org/library/papers/32536012PubMed
1915641020Molecular mechanisms of drug resistance.J Pathol2005https://conductscience.org/library/papers/15641020PubMed
2028430641The regulation of β-catenin activity and function in cancer: therapeutic opportunities.Oncotarget2017https://conductscience.org/library/papers/28430641PubMed

See all 63 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42985483Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study.Oncol Res2026https://conductscience.org/library/papers/42985483PubMed
42588722Targeting β-Adrenergic Signaling in Colorectal Cancer: Molecular Mechanisms and Therapeutic Potential of β-Blockers.Cancers (Basel)2026https://conductscience.org/library/papers/42588722PubMed
42212159Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic.Front Immunol2026https://conductscience.org/library/papers/42212159PubMed
41866332Propranolol enhances the oncolytic effect of newcastle disease virus on canine mammary tumor cell by modulating the IFN-I-mediated JAK-STAT signaling pathway.Vet Q2026https://conductscience.org/library/papers/41866332PubMed
41509003Beta-Blocker Use and Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis.Clin Med Insights Oncol2026https://conductscience.org/library/papers/41509003PubMed
41316431Neural regulation of lung cancer: from mechanisms to clinical implications.Eur J Med Res2025https://conductscience.org/library/papers/41316431PubMed
41309043Beta-blocker use and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis.J Int Med Res2025https://conductscience.org/library/papers/41309043PubMed
41256756Propranolol Treatment Reduces A549-Derived Lung Cancer Spheroids via Intrinsic Apoptosis.J Clin Pract Res2023https://conductscience.org/library/papers/41256756PubMed
41256263Propranolol (1 mg/kg/day) with intralesional bleomycin versus propranolol monotherapy for infantile hemangioma: a randomized controlled trial.Front Pharmacol2025https://conductscience.org/library/papers/41256263PubMed
41178927Neuro-tumor interactions: Multi-dimensional mechanisms of neurotransmitter regulation in tumor immune evasion and metabolic reprogramming.World J Clin Oncol2025https://conductscience.org/library/papers/41178927PubMed
40914425Unraveling the nexus in the neuro-neoplastic progression of colorectal cancer: Potential role of β2-adrenergic receptor (β2-AR).J Adv Res2026https://conductscience.org/library/papers/40914425PubMed
40842986Impact of beta blockers on cancer neuroimmunology: a systematic review and meta-analysis of survival outcomes and immune modulation.Front Immunol2025https://conductscience.org/library/papers/40842986PubMed
40361395Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy.Cancers (Basel)2025https://conductscience.org/library/papers/40361395PubMed
39640497The β3-Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential.Adv Pharmacol Pharm Sci2024https://conductscience.org/library/papers/39640497PubMed
39492832Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk.MedComm (2020)2024https://conductscience.org/library/papers/39492832PubMed
39178356Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.J Clin Oncol2024https://conductscience.org/library/papers/39178356PubMed
38976162The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders.FASEB J2024https://conductscience.org/library/papers/38976162PubMed
38505269PPARG and the PTEN-PI3K/AKT Signaling Axis May Cofunction in Promoting Chemosensitivity in Hypopharyngeal Squamous Cell Carcinoma.PPAR Res2024https://conductscience.org/library/papers/38505269PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37446271

GET https://conductscience.org/api/papers/v1/37446271/references?page=2